Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do we need to improve pain management in the radiation oncology department?

Nature Clinical Practice Oncology volume 2, pages 130–131 (2005)Cite this article

boxed-textPignon T et al. (2004) Impact of radiation oncology practice on pain: a cross-sectional survey. Int J Radiat Oncol Biol Phys 60: 1204–1210

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Janjan NA et al. (2003) Palliative care. In Radiation Oncology; Rationale, Technique, Results, 954–986 (Eds Cox JD and Ang KK) Edn 8. Philadelphia: WB Saunders

    Google Scholar 

  2. SCOPE Steering Committee and Subcommittees (2002) Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE). Int J Radiat Oncol Biol Phys 54: 317–326

  3. Horiot JC (2004) Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting? Int J Radiat Oncol Biol Phys 60: 1018–1025

    Article  Google Scholar 

  4. Cleeland CS et al. (2000) Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys 47: 203–208

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Radiation Oncology at the University of Texas M.D. Anderson Cancer Center,

    Nora Janjan

Authors
  1. Nora Janjan
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Dr Janjan is on the Medical Advisory Board for the Cancer Research Foundation of America; the Oncology Advisory Board for Medtronics Corporation, Neurological Division (as a contributor in the development of the inter-institutional trial, 'A randomized evaluation of Medtronic intrathecal drug delivery systems for cancer pain unrelieved by standard measures'); the Educational Advisory Board and Oncology National Advisory Board for Berlex Laboratories, Quadramet Division; the Research Advisory Board for Clinimetrix/Alza Pharmaceuticals (Committee for Study #C-2000-025, Clinical Investigator Board); the Advisory Board for Aesgen; and the Advisory Board for Unitech. Dr Janjan has received consulting fees from Gerson Lehrman Group, Cadent Medical Communications, and the Opinion Leader Group, and a grant from Roche Pharmaceuticals as the Principal Investigator in 'An open label phase II study of capecitabine in combination with preoperative pelvic radiotherapy using the concomitant boost technique in rectal cancer (ID02-009; CS2002-071OH).

Glossary

SOFRED

The Francophone Society for the Study and Evaluation of Pain

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janjan, N. Do we need to improve pain management in the radiation oncology department?. Nat Rev Clin Oncol 2, 130–131 (2005). https://doi.org/10.1038/ncponc0111

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0111

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing